A/s Novo, 10% Owner at Tobira Therapeutics, Inc. (TBRA), sold 190,000 shares at $6.54 ($1.3M) on 2016-03-04, disclosed to the SEC on 2016-03-04.
Open-market sale of $1.3M TBRA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.92 | 110,000 | $761K | 58.9% |
| 2 | $6.86 | 25,000 | $172K | 13.3% |
| 3 | $6.54 | 55,000 | $360K | 27.8% |
| Total | $6.80 avg | 190,000 | $1.3M | 100% |
| Filing → |
| RETA | SELL | 2017-06-07 | $2.5M | — | Filing → |
| APEN | SELL | 2017-05-11 | $582K | — | Filing → |
| OPHT | SELL | 2016-12-16 | $17.6M | — | Filing → |